FoRx Therapeutics AG appoints Frank Zenke as Chief Scientific Officer

Aug 1, 2023

Back to news FoRx Therapeutics AG appoints Frank Zenke as Chief Scientific Officer Basel, Switzerland, 01 August 2023 – FoRx Therapeutics, an incorporated privately held company developing first-in-class compounds for cancer treatment, today announces the appointment...

FoRx Therapeutics AG appoints Tarig Bashir as Chief Executive Officer

Apr 1, 2021

Back to news FoRx Therapeutics AG appoints Tarig Bashir as Chief Executive Officer Basel, Switzerland, 01 April, 2021 – FoRx Therapeutics, a recently incorporated privately-held company developing first-in-class compounds for cancer treatment, today announces the...

FoRx Therapeutics AG appoints Ulrich Lücking as Head of Chemistry

Jun 1, 2020

Back to news FoRx Therapeutics AG appoints Ulrich Lücking as Head of Chemistry Basel, Switzerland, 01 June, 2020 – FoRx Therapeutics, a recently incorporated privately-held company developing first-in-class compounds for cancer treatment, today announces the...